KK-LC-1 TCR-T Cell Therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for KK-LC-1 TCR-T Cell Therapy, covering 2025-03-30 to 2025-03-30. Get the full timeline:
Most recent: Clinical Trial Update: KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer [Phase 1]